Kai Dallmeier

This study evaluates cross-protection of Ebola and Sudan vaccines against Bundibugyo virus using a surrogate challenge model in mice, finding partial protection and suggesting non-neutralizing mechanisms play a role.

This study develops a yellow fever 17D reporter virus expressing thymidine kinase to enable prodrug activation and bioorthogonal labeling of infected cells for tracking viral replication and tissue tropism.

This study identifies how dengue virus uses mosquito Syntenin to package and secrete viral RNA into salivary exosomes, revealing a mechanism for viral RNA incorporation into extracellular vesicles.

This paper identifies a molecular marker for sex determination in Syrian hamster pups using placental tissues, achieving 85% specificity in sex classification.

This paper develops a high-throughput imaging platform for RV-C research and antiviral drug discovery, identifying inhibitors through compound screening.

This study shows that antigenic imprinting limits neutralizing antibody responses to new SARS-CoV-2 variants in hamsters, suggesting challenges for vaccine efficacy against emerging subvariants.

This paper demonstrates that ex vivo midgut cultures of Aedes aegypti mosquitoes can be efficiently infected by mosquito-borne alpha- and flaviviruses and used to test antiviral compounds.

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.